CORT
Corcept Therapeutics Inc
Price:  
72.60 
USD
Volume:  
592,313.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CORT Relative Valuation

-71.2%
Upside

As of 2025-02-19, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 20.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 72.60 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -71.2%.

The range of the Relative Valuation is 11.90 - 31.02 USD.

Range Selected
Trailing P/E multiples 14.3x - 22.9x 17.8x
Forward P/E multiples 10.3x - 20.3x 15.3x
Fair Price 11.90 - 31.02 20.92
Upside -83.6% - -57.3% -71.2%
72.60 USD
Stock Price
20.92 USD
Fair Price

CORT Relative Valuation - Historical P/E Data

Date P/E
2025-02-14 53.73
2025-02-13 54.39
2025-02-12 51.83
2025-02-11 50.32
2025-02-10 49.90
2025-02-07 50.25
2025-02-06 50.27
2025-02-05 50.57
2025-02-04 49.44
2025-02-03 49.17
2025-01-31 49.44
2025-01-30 51.64
2025-01-29 45.46
2025-01-28 44.82
2025-01-27 44.55
2025-01-24 44.32
2025-01-23 46.02
2025-01-22 43.61
2025-01-21 45.15
2025-01-17 40.86
2025-01-16 40.22
2025-01-15 39.73
2025-01-14 38.17
2025-01-13 37.72
2025-01-10 36.83
2025-01-08 38.19
2025-01-07 37.87
2025-01-06 38.17
2025-01-03 37.57
2025-01-02 36.92
2024-12-31 37.23
2024-12-30 37.57
2024-12-27 38.77
2024-12-26 39.62
2024-12-24 38.54
2024-12-23 37.61
2024-12-20 37.98
2024-12-19 37.79
2024-12-18 38.73
2024-12-17 40.74
2024-12-16 40.95
2024-12-13 40.93
2024-12-12 41.61
2024-12-11 44.39
2024-12-10 43.45
2024-12-09 43.78
2024-12-06 44.91
2024-12-05 43.90
2024-12-04 44.96
2024-12-03 44.09